Clinical trial
Application of the AI Platform iLN Based on DeepSeek in the Teaching of Lupus Nephritis
NCT07706998 is registered in ClinicalTrials.gov with Nanjing University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Application of the AI Platform iLN Based on DeepSeek in the Teaching of Lupus Nephritis
- Lead sponsor
- Nanjing University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- July 1, 2026
- Completion date
- December 31, 2026
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
learning